Bioanalysis—Three Decades in the Making
Improving Your Quality Toolbox with Quality Metrics
Five Reasons to Choose Canada for Your Clinical Trials—From the Webinar Demystifying the Conduct of Clinical Trials in Canada
Canadian research facilities are becoming a popular choice for American and European sponsors, carrying out hundreds of clinical trials each year.
Up Close and Personal With Jeff Plomley
Jeff received his graduate degree in Chemistry from Queens University. He focused the first decade of his career in mass spectrometry on instrumentation research and product development, designing novel scan functions for both 2D and 3D ion traps.
Hybridization LC-MS/MS Workflow to Quantify an siRNA Drug Candidate in Plasma, CSF, and Tissues
ISSUE NO. 31 — The Advantages of Conducting Early-Phase Clinical Research in Canada
Timely completion of necessary studies is a critical element of drug development, bringing important treatments to patients in a safe and cost-efficient way. A consideration with a measurable impact on early-phase clinical studies is the location where trials are performed; this is especially true for first-in-human (FIH) trials.
Conducting early-phase clinical research on novel compounds in Canada can provide significant advantages versus other locations.
In Issue 31 of The Altascientist, we take a deep dive into these advantages, covering:
- Canadian CTA trials–time and cost savings
- Regulatory review process predictability
- Business efficiency cost savings
- Clinical trial participants
Scratching the Surface of Dermal Testing
Dr. Keyhani Reflects on International Day of Women and Girls in Science
Opinion | A Day to Celebrate, and a Call to Action
Dr.